ODS-2004436

N/A

Report date: 2025/11/24 17:58:33
NME

Base Information

Drug NameODS-2004436
Drug Alias NameODS-2006405-1ODS-2004436[18F]ODS-2004436
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncodesign Biotechnology SACyclopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncodesign Biotechnology SACyclopharma
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A